Pregabalin pharmacology and its relevance to clinical practice

Epilepsia

Volumn 45, Issue SUPPL. 6, 2004, Pages 13-18

  Ben Menachem, Elinor ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Adjunctive therapy; Alpha 2 delta; Animal models; Antiepileptic drugs; Drug interactions; Partial seizures; Pharmacokinetics; Pharmacology; Pregabalin

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALCOHOL; BENZODIAZEPINE RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CARBAMAZEPINE; CYTOCHROME P450; DIURETIC AGENT; GABAPENTIN; GLUTAMIC ACID; INSULIN; LAMOTRIGINE; LIGAND; LORAZEPAM; NORADRENALIN; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; OXYCODONE; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; SUBSTANCE P; TOPIRAMATE; VALPROIC ACID; VOLTAGE GATED CALCIUM CHANNEL;

BLOOD BRAIN BARRIER; CALCIUM TRANSPORT; CLINICAL TRIAL; CLONIC SEIZURE; COGNITIVE DEFECT; CONFERENCE PAPER; DEPOLARIZATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; EPILEPSY; ETHNIC DIFFERENCE; FOCAL EPILEPSY; FOOD DRUG INTERACTION; GRAND MAL SEIZURE; HUMAN; KIDNEY FAILURE; LIGAND BINDING; MOTOR DYSFUNCTION; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; STEADY STATE; TONIC CLONIC SEIZURE; TONIC SEIZURE;

EID: 5344249471     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.455003.x     Document Type: Conference Paper

References (27)

1. Kwan P, Brodie MJ. Early identification of refractory epilepsy. New Engl J Med 2000;342:314-9.
2. Leppik IE. Issues in the treatment of epilepsy. Epilepsia 2001;42(suppl 4):1-6.
3. Faught E. Pharmacokinetic considerations in prescribing antiepileptic drugs. Epilepsia 2001;42(suppl 4):19-23.
4. Walker MC, Patsalos PN. Clinical pharmacokinetics of new antiepileptic drugs. Pharmacol Ther 1995;67:351-84.
5. Ben-Menachem E, Kugler AR. Pregabalin and epilepsy. In: Shorvon S, Fish D, Dodson W, Perruca E, eds. Treatment of epilepsy. 2nd edition. Oxford: Blackwell Publishing Ltd, Oxford (in press).
6. Ben-Menachem E, Kugler AR. Pregabalin. In: Levy RH, Mattson RH, Meldrum BS, Perucca E, eds. Antiepileptic drugs. 5th edition. Philadelphia: Lippincott Williams & Wilkins, 2002:901-5.
7. Kugler AR, Robbins JL, Strand JC, et al. Pregabalin overview: a novel CNS-active compound with anticonvulsant activity. Poster presented at the Annual Meeting of the American Epilepsy Society, Seattle, Washington, December 6-11, 2002.
8. Lauria-Horner BA, Pohl RB. Pregabalin: a new anxiolytic. Expert Opin Investig Drugs 2003;12:663-72.
9. Taylor CP, Vartanian MG, Yuen P, Bigge C, Suman-Chauhan N, Hill DR. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin. Epilepsy Res 1993;14:11-5.
10. Fink K, Dooley DJ, Meder WP, et al. Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 2002;42:229-36.
11. Dooley DJ, Donovan CM, Pugsley TA. Stimulus-dependent modulation of [3H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin. J Pharmacol Exp Ther 2000;295:1086-93.
12. Dooley DJ, Mieske CA, Borosky SA. Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neurosci Lett 2000;280:107-10.
13. Suman-Chauhan N, Webdale L, Hill DR, Woodruff GN. Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies. Eur J Pharmacol 1993;244:293-301.
14. Taylor CP. Meeting report: The biology and pharmacology of calcium channel alpha-2-delta proteins. (Pfizer Satellite symposium to the 2003 Society for Neuroscience Meeting, New Orleans, LA, October 10, 2003) CNS Drug Reviews 2004;10:159-64.
15. Errante LD, Petroff OA. Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure 2002;12:300-6.
16. Brigell MG, Carter CM, Smith F, Garofalo EA. Prospective evaluation of the ophthalmologic safety of pregabalin shows no evidence of toxicity. Poster presented at the Annual Meeting of the American Epilepsy Society, Seattle, Washington, December 6-11, 2002.
17. Taylor CP, Vartanian MG. Profile of the anticonvulsant activity of CI-1008 (pregabalin) in animal models. Epilepsia 1997;38(suppl 8):8.
18. Williamson J, Lothman CTE, Bertran E. Comparison of S(+)-3 Isobutyl GABA and gabapentin against kindled hippocampal seizures. Epilepsia 1997;38(suppl 8):29.
19. Andre VV, Rigoulot MA, Koning E, Ferrandon A, Nehlig A. Long-term pregabalin treatment protects basal cortices and delays the occurrence of spontaneous seizures in the lithium-pilocarpine model in the rat. Epilepsia 2003;44:893-903.
20. Bockbrader HN, Hunt T, Strand J, et al. Pregabalin pharmacokinetics and safety in healthy volunteers: results from two phase 1 studies. Neurology 2000;54(suppl 3):421.
21. Perucca E, Ramsay RE, Robbins JL, Kugler AR, Anhut H, Knapp LE. Pregabalin demonstrates anticonvulsant activity onset by the second day. Poster presented at the Annual Meeting of the American Epilepsy Society, Seattle, December 6-11, 2002.
22. Brodie MJ. Pregabalin as adjunctive therapy for partial seizures. Epilepsia 2004;45(suppl 6):19-27.
23. Randinitis EJ, Posvar EL, Alvey CW, Sedman AJ, Cook JA, Bockbrader HN. Pharmacokinetics of pregabalin in subjects with various degrees of renal function. J Clin Pharmacol 2003;43:277-83.
24. Bockbrader HN, Strand JC, Wesche DL, et al. Drug interaction studies of pregabalin (CI-1008, PGB) in patients with epilepsy maintained on either valproate (VA), lamotrigine (LMG), phenytoin (PHY) or carbamazepine (CBZ). Poster presented at the 5th European Congress of Epileptology, Madrid, October 6-10, 2002.
25. Bockbrader HN, Burger PJ, Kugler AR, et al. Population pharmacokinetic (PK) analyses of commonly prescribed antiepileptic drugs (AEDs) co-administered with pregabalin (PGB) in adult patients with refractory partial seizures. Epilepsia 2001;42(suppl 7):84.
26. Bockbrader HN, Burger P, Corrigan BW. Pharmacokinetics of pregabalin in patients with chronic pain. In: 10th World Congress on Pain-Book of Abstracts. IASP 2002 Scientific Program Committee, ed. Seattle, WA: IASP Press, 2002:199.
27. Lyrica. EU Summary of product characteristics. EU/1/04/279/001-025.